Skip to main content
Top
Published in: Critical Care 1/2003

Open Access 01-02-2002 | Research

Cost of intensive care in a Norwegian University hospital 1997–1999

Authors: Hans Flaatten, Reidar Kvåle

Published in: Critical Care | Issue 1/2003

Login to get access

Abstract

Aim

The present study was performed in order to document costs of intensive care in a Norwegian university hospital and to perform an average cost-effectiveness study using the expected remaining life-years in survivors after 18 months.

Materials and methods

Patients admitted to the general intensive care unit (ICU) at Haukeland University Hospital from 1997 to 1999 were followed up to 18 months post ICU using data from the Norwegian Peoples' registry. Our ICU patients have a further mortality equal to the average population in Norway from that time. By creating an age-matched and sex-matched sample of the general Norwegian population equal to survivors 18 months after ICU treatment, we could find the expected further survival time for each ICU survivor. Direct and indirect ICU expenses in the study period were retrieved using a 'top-down' method. Outcome assessment was performed using the total ICU expenses in the period divided by the sum of the life expectancy (years) in survivors after 18 months.

Results

The total ICU costs (converted to 2001 values) were € 16,697,415, excluding the costs of radiology and the use of operating theatres, which were both impossible to retrieve. A total of 1051 patients were treated, of whom 60.9% survived up to 18 months. Further total life expectancies were 24,428 years. The average costs of an ICU day and stay per patient were € 2601 and € 14,223, respectively, and the average cost per year of survival per patient was € 684.

Discussion

The absolute costs were found to be higher than recent European ICU studies reporting on the cost of ICU treatment. However, the price of a further life-year in survivors was lower and was comparable with other medical treatment.
Literature
1.
go back to reference Chalfin DB, Cohen IL, Lambrinos J: The economics and cost-effectiveness of critical care medicine. Intensive Care Med. 1995, 21: 952-961.CrossRefPubMed Chalfin DB, Cohen IL, Lambrinos J: The economics and cost-effectiveness of critical care medicine. Intensive Care Med. 1995, 21: 952-961.CrossRefPubMed
2.
go back to reference Edbrooke DL, Stevens VG, Hibbert CL, Mann AJ, Wilson AJ: A new method of accurately identifying costs of individual patients in intensive care: the initial results. Intensive Care Med. 1997, 23: 645-650. 10.1007/s001340050388.CrossRefPubMed Edbrooke DL, Stevens VG, Hibbert CL, Mann AJ, Wilson AJ: A new method of accurately identifying costs of individual patients in intensive care: the initial results. Intensive Care Med. 1997, 23: 645-650. 10.1007/s001340050388.CrossRefPubMed
3.
go back to reference Gyldmark M: A review of cost studies of intensive care units: problems with the cost concept. Crit Care Med. 1995, 23: 964-972. 10.1097/00003246-199505000-00028.CrossRefPubMed Gyldmark M: A review of cost studies of intensive care units: problems with the cost concept. Crit Care Med. 1995, 23: 964-972. 10.1097/00003246-199505000-00028.CrossRefPubMed
4.
go back to reference Edbrooke D, Hibbert C, Ridley S, Long T, Dickie H: The development of a method for comparative costing of individual intensive care units. The Intensive Care Working Group on Costing. Anaesthesia. 1999, 54: 110-120. 10.1046/j.1365-2044.1999.00650.x.CrossRefPubMed Edbrooke D, Hibbert C, Ridley S, Long T, Dickie H: The development of a method for comparative costing of individual intensive care units. The Intensive Care Working Group on Costing. Anaesthesia. 1999, 54: 110-120. 10.1046/j.1365-2044.1999.00650.x.CrossRefPubMed
5.
go back to reference Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C: A model to compute the medical cost of patients in intensive care. Pharmacoeconomics. 1999, 15: 573-582.CrossRefPubMed Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C: A model to compute the medical cost of patients in intensive care. Pharmacoeconomics. 1999, 15: 573-582.CrossRefPubMed
6.
go back to reference Flaatten H, Austlid I: REGINA, developement of a database concept in intensive care medicine [abstract]. Acta Anesthesiol Scand. 1997, 41 (suppl 110): 193- Flaatten H, Austlid I: REGINA, developement of a database concept in intensive care medicine [abstract]. Acta Anesthesiol Scand. 1997, 41 (suppl 110): 193-
7.
go back to reference Le Gall J, Lemeshow S, Saulnier F: A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993, 270: 2957-2563. 10.1001/jama.270.24.2957.CrossRefPubMed Le Gall J, Lemeshow S, Saulnier F: A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993, 270: 2957-2563. 10.1001/jama.270.24.2957.CrossRefPubMed
8.
go back to reference Miranda R, Moreno R, Iapichino G: Nine equivalent of nursing manpower use score (NEMS). Intensive Care Med. 1997, 23: 760-765. 10.1007/s001340050406.CrossRef Miranda R, Moreno R, Iapichino G: Nine equivalent of nursing manpower use score (NEMS). Intensive Care Med. 1997, 23: 760-765. 10.1007/s001340050406.CrossRef
9.
go back to reference Flaatten H, Kvale R: Survival and quality of life 12 years after ICU. A comparison with the general Norwegian population. Intensive Care Med. 2001, 27: 1005-1011. 10.1007/s001340100960.CrossRefPubMed Flaatten H, Kvale R: Survival and quality of life 12 years after ICU. A comparison with the general Norwegian population. Intensive Care Med. 2001, 27: 1005-1011. 10.1007/s001340100960.CrossRefPubMed
10.
go back to reference Statistics Norway: 84 Expected Survival Time (Forventet Gjenstående Levetid). 2000, Oslo: Statistics Norway Statistics Norway: 84 Expected Survival Time (Forventet Gjenstående Levetid). 2000, Oslo: Statistics Norway
11.
go back to reference Eisenberg J: Clinical economics. A guide to the economic analysis of clinical practice. J Am Med Assoc. 1989, 262: 2879-2886. 10.1001/jama.262.20.2879.CrossRef Eisenberg J: Clinical economics. A guide to the economic analysis of clinical practice. J Am Med Assoc. 1989, 262: 2879-2886. 10.1001/jama.262.20.2879.CrossRef
12.
go back to reference Siegel JE, Weinstein MC, Russell LB, Gold MR: Recommendations of the Panel of Cost-Effectiveness in Health and Medicine. J Am Med Assoc. 1996, 276: 1253-1258. 10.1001/jama.276.16.1339.CrossRef Siegel JE, Weinstein MC, Russell LB, Gold MR: Recommendations of the Panel of Cost-Effectiveness in Health and Medicine. J Am Med Assoc. 1996, 276: 1253-1258. 10.1001/jama.276.16.1339.CrossRef
13.
go back to reference Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001, 344: 699-709. 10.1056/NEJM200103083441001.CrossRefPubMed Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001, 344: 699-709. 10.1056/NEJM200103083441001.CrossRefPubMed
14.
go back to reference Edbrooke DL, Ridley SA, Hibbert CL, Corcoran M: Variations in expenditure between adult general intensive care units in the UK. Anaesthesia. 2001, 56: 208-216. 10.1046/j.1365-2044.2001.01716.x.CrossRefPubMed Edbrooke DL, Ridley SA, Hibbert CL, Corcoran M: Variations in expenditure between adult general intensive care units in the UK. Anaesthesia. 2001, 56: 208-216. 10.1046/j.1365-2044.2001.01716.x.CrossRefPubMed
15.
go back to reference Graf J, Graf C, Janssens U: Analysis of resource use and cost-generating factors in a German medical intensive care unit employing the Therapeutic Intervention Scoring System (TISS-28). Intensive Care Med. 2002, 28: 324-331. 10.1007/s00134-001-1201-6.CrossRefPubMed Graf J, Graf C, Janssens U: Analysis of resource use and cost-generating factors in a German medical intensive care unit employing the Therapeutic Intervention Scoring System (TISS-28). Intensive Care Med. 2002, 28: 324-331. 10.1007/s00134-001-1201-6.CrossRefPubMed
16.
go back to reference Manns BJ, Lee H, Doig CJ, Johnson D, Donaldson C: An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med. 2002, 347: 993-1000. 10.1056/NEJMsa020969.CrossRefPubMed Manns BJ, Lee H, Doig CJ, Johnson D, Donaldson C: An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med. 2002, 347: 993-1000. 10.1056/NEJMsa020969.CrossRefPubMed
17.
go back to reference United Nations: Table 6. Commitment to health: access services and resources. Human Development Report 2001. 2001, Oxford: Oxford University Press, 158- United Nations: Table 6. Commitment to health: access services and resources. Human Development Report 2001. 2001, Oxford: Oxford University Press, 158-
18.
go back to reference Hibbert C, Edbrook D: Economic outcomes. In Outcomes in Critical Care. Edited by: Ridley S. 2002, Oxford: Butterworth Heinemann, 202-222. Hibbert C, Edbrook D: Economic outcomes. In Outcomes in Critical Care. Edited by: Ridley S. 2002, Oxford: Butterworth Heinemann, 202-222.
19.
go back to reference Heyland DK, Konopad E, Noseworthy TW, Johnston R, Gafni A: Is it 'worthwhile' to continue treating patients with a prolonged stay (>14 days) in the ICU? An economic evaluation. Chest. 1998, 114: 192-198.CrossRefPubMed Heyland DK, Konopad E, Noseworthy TW, Johnston R, Gafni A: Is it 'worthwhile' to continue treating patients with a prolonged stay (>14 days) in the ICU? An economic evaluation. Chest. 1998, 114: 192-198.CrossRefPubMed
20.
go back to reference Kvåle R, Flaatten H: Changes in intensive care from 1987 to 1997 – has outcome improved? A single center study. Intensive Care Med. 2002, 28: 1110-1116. 10.1007/s00134-002-1378-3.CrossRefPubMed Kvåle R, Flaatten H: Changes in intensive care from 1987 to 1997 – has outcome improved? A single center study. Intensive Care Med. 2002, 28: 1110-1116. 10.1007/s00134-002-1378-3.CrossRefPubMed
21.
go back to reference Angus DC, Musthafa AA, Clermont G, Griffin MF, Linde-Zwirble WT, Dremsizov TT, Pinsky MR: Quality-adjusted survival in the first year after the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001, 163: 1389-1394.CrossRefPubMed Angus DC, Musthafa AA, Clermont G, Griffin MF, Linde-Zwirble WT, Dremsizov TT, Pinsky MR: Quality-adjusted survival in the first year after the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001, 163: 1389-1394.CrossRefPubMed
22.
go back to reference Kerridge RK, Glasziou PP, Hillman KM: The use of 'quality-adjusted life years' (QALYs) to evaluate treatment in intensive care. Anaesth Intensive Care. 1995, 23: 322-331.PubMed Kerridge RK, Glasziou PP, Hillman KM: The use of 'quality-adjusted life years' (QALYs) to evaluate treatment in intensive care. Anaesth Intensive Care. 1995, 23: 322-331.PubMed
23.
go back to reference Hamel MB, Phillips RS, Davis RB, Teno J, Connors AF, Desbiens N, Lynn J, Dawson NV, Fulkerson W, Tsevat J: Outcomes and cost-effectiveness of ventilator support and aggressive care for patients with acute respiratory failure due to pneumonia or acute respiratory distress syndrome. Am J Med. 2000, 109: 614-620. 10.1016/S0002-9343(00)00591-X.CrossRefPubMed Hamel MB, Phillips RS, Davis RB, Teno J, Connors AF, Desbiens N, Lynn J, Dawson NV, Fulkerson W, Tsevat J: Outcomes and cost-effectiveness of ventilator support and aggressive care for patients with acute respiratory failure due to pneumonia or acute respiratory distress syndrome. Am J Med. 2000, 109: 614-620. 10.1016/S0002-9343(00)00591-X.CrossRefPubMed
Metadata
Title
Cost of intensive care in a Norwegian University hospital 1997–1999
Authors
Hans Flaatten
Reidar Kvåle
Publication date
01-02-2002
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2003
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc1865

Other articles of this Issue 1/2003

Critical Care 1/2003 Go to the issue